H Kristofová

631 total citations
35 papers, 557 citations indexed

About

H Kristofová is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, H Kristofová has authored 35 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in H Kristofová's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (6 papers) and Immunotherapy and Immune Responses (6 papers). H Kristofová is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (6 papers) and Immunotherapy and Immune Responses (6 papers). H Kristofová collaborates with scholars based in Czechia, Austria and Russia. H Kristofová's co-authors include I Hilgert, Václav Hořejšı́, Irena Štefanová, V Bažil, Miroslav Baudyš, Jack L. Strominger, M G Low, R.J. Brown, Pavla Angelisová and Antonín Bukovský and has published in prestigious journals such as Nature, European Journal of Immunology and Journal of Immunological Methods.

In The Last Decade

H Kristofová

34 papers receiving 530 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H Kristofová 369 182 95 80 52 35 557
Peter Rohwer 409 1.1× 149 0.8× 79 0.8× 44 0.6× 59 1.1× 22 656
C.R. Bird 203 0.6× 124 0.7× 61 0.6× 37 0.5× 62 1.2× 13 437
Ria van Nieuwmegen 375 1.0× 338 1.9× 140 1.5× 44 0.6× 38 0.7× 22 742
P Liacopoulos 398 1.1× 282 1.5× 232 2.4× 97 1.2× 38 0.7× 102 789
Arnold Vogt 133 0.4× 199 1.1× 84 0.9× 63 0.8× 35 0.7× 32 573
J W Uhr 406 1.1× 124 0.7× 150 1.6× 32 0.4× 49 0.9× 26 590
B. Cinader 308 0.8× 179 1.0× 126 1.3× 35 0.4× 54 1.0× 33 684
Thorbecke Gj 294 0.8× 79 0.4× 81 0.9× 45 0.6× 22 0.4× 20 449
Alexander H. Taylor 198 0.5× 176 1.0× 59 0.6× 66 0.8× 100 1.9× 10 425
Henry Chang 464 1.3× 207 1.1× 48 0.5× 36 0.5× 63 1.2× 11 729

Countries citing papers authored by H Kristofová

Since Specialization
Citations

This map shows the geographic impact of H Kristofová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kristofová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kristofová more than expected).

Fields of papers citing papers by H Kristofová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Kristofová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kristofová. The network helps show where H Kristofová may publish in the future.

Co-authorship network of co-authors of H Kristofová

This figure shows the co-authorship network connecting the top 25 collaborators of H Kristofová. A scholar is included among the top collaborators of H Kristofová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Kristofová. H Kristofová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilgert, I, František Franěk, Irena Štefanová, et al.. (1993). Therapeutic in vivo use of the A1-CD3 monoclonal antibody.. PubMed. 55(2). 435–8. 3 indexed citations
2.
Hilgert, I, P Stolba, H Kristofová, et al.. (1991). A Monoclonal Antibody Applicable for Determination of C-Peptide of Human Proinsulin by RIA. Hybridoma. 10(3). 379–386. 5 indexed citations
3.
Štefanová, Irena, et al.. (1990). Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein.. PubMed. 36(1). 41–50. 34 indexed citations
4.
Štefanová, Irena, I Hilgert, V Bažil, H Kristofová, & Václav Hořejšı́. (1989). Human leucocyte surface glycoprotein CDw44 and lymphocyte homing receptor are identical molecules. Immunogenetics. 29(6). 402–404. 12 indexed citations
5.
Štefanová, Irena, I Hilgert, H Kristofová, et al.. (1989). Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Molecular Immunology. 26(2). 153–161. 121 indexed citations
6.
Bažil, V, et al.. (1989). Sialic acid-dependent epitopes of CD45 molecules of restricted cellular expression. Immunogenetics. 29(3). 202–205. 10 indexed citations
7.
Štefanová, Irena, et al.. (1988). Monoclonal antibodies against human α-fetoprotein exploitation of an unusual calcium-dependent interaction with the antigen for analytical and preparative purposes. Journal of Immunological Methods. 111(1). 67–73. 23 indexed citations
8.
Kristofová, H, et al.. (1988). Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).. PubMed. 34(1). 23–34. 16 indexed citations
9.
Hilgert, I, et al.. (1986). Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen.. PubMed. 32(1). 12–25. 20 indexed citations
10.
11.
Hilgert, I, et al.. (1984). The effect of lentil lectin treatment on the survival of rat skin allografts in strain combinations with different genetic disparity.. PubMed. 30(2). 104–8. 1 indexed citations
12.
Kristofová, H, et al.. (1983). Adult transplantation tolerance induced by lentil lectin. I. The fate of tolerogenic lentil seed lectin after injection into mice.. PubMed. 29(3). 230–7. 1 indexed citations
13.
Hilgert, I, Václav Hořejšı́, Pavla Angelisová, & H Kristofová. (1980). Lentil lectin effectively induces allotransplantation tolerance in mice. Nature. 284(5753). 273–275. 12 indexed citations
14.
Rieger, Michael A., et al.. (1978). Evidence of suppresssor cell-mechanism of allograft tolerance induced by spleen extract and hydrocortisone.. PubMed. 24(3). 145–61. 2 indexed citations
15.
Hilgert, I, et al.. (1976). The intersex difference in the production of alloantibodies and growth of tumour allografts in mice.. PubMed. 22(4). 253–63. 2 indexed citations
16.
Hilgert, I, H Kristofová, & Michael A. Rieger. (1975). Allograft tolerance as in immunologically active process: analysis in a restricted H-2 incompatibility due to mutation (M504) in mouse strain B10.D2.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(6). 409–13. 6 indexed citations
17.
Tlaskalová, H., et al.. (1974). Interactions of lymphoid cells with transplantation antigens bound to immunoadsorbent.. PubMed. 20(5). 340–2. 3 indexed citations
18.
Hilgert, I, et al.. (1973). Chemical nature of mouse histocompatibility antigens. I. Solubilization of H-2 antigens by means of autolysis, cholate and high ionic strength.. PubMed. 19(6). 385–96. 1 indexed citations
19.
Hilgert, I, et al.. (1971). A study on immunological unresponsiveness to skin allografts induced by cell-free liver extract.. PubMed. 17(4). 214–9. 1 indexed citations
20.
Hilgert, I & H Kristofová. (1967). Decreased graft-responsiveness in mice induced by cell-free tissue extracts.. PubMed. 13(4). 284–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026